Cargando…

Investigation of Effect of the Colistin Loading Dosage on the clinical, Microbiological, and Laboratory Results in Acinetobacter baumannii Ventilator-Associated Pneumonia /Pneumonia

MATERIALS AND METHODS: Adult patients administered colistin with and without LD for MDR Acinetobacter baumannii VAP/pneumonia in intensive care units (ICUs) in a tertiary teaching hospital between 1 January 2018 and 31 December 2019 were included in this retrospective cohort study. The primary endpo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Keski̇n, Ayşegül Seremet, Seyman, Derya, Önder, Kübra Demir, Kizilateş, Filiz, Keski̇n, Olgun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9441370/ https://www.ncbi.nlm.nih.gov/pubmed/36105785 http://dx.doi.org/10.1155/2022/5437850

Ejemplares similares

Factors associated with development of an acute ischemic event during hospitalization for COVID-19 in cancer and non-cancer patients
por: Onder, Arif Hakan, et al.
Publicado: (2023)

A Prognostic Marker in COVID-19 Disease Severity and Mortality: D-Dimer/Platelet Ratio
por: Tahmaz, Alper, et al.
Publicado: (2023)

Should Preventive Antifungal Treatment Be Given to Patients With Abdominal Contamination in the Intensive Care Unit?
por: Demir Onder, Kubra, et al.
Publicado: (2023)

Is Homocysteine Associated with the Prognosis of Covid-19 Pneumonia
por: Kalan Sarı, Işılay, et al.
Publicado: (2023)

Is inhaled colistin beneficial in ventilator associated pneumonia or nosocomial pneumonia caused by Acinetobacter baumannii?
por: Demirdal, Tuna, et al.
Publicado: (2016)

Colistin Dosage without Loading Dose Is Efficacious when Treating Carbapenem-Resistant Acinetobacter baumannii Ventilator-Associated Pneumonia Caused by Strains with High Susceptibility to Colistin
por: Álvarez-Marín, Rocío, et al.
Publicado: (2016)

Inhaled Colistin for Treatment of Pneumonia due to Colistin-Only-Susceptible Acinetobacter baumannii
por: Choi, Hee Kyoung, et al.
Publicado: (2014)

Colistin Plus Carbapenem versus Colistin Monotherapy in the Treatment of Carbapenem-Resistant Acinetobacter baumannii Pneumonia
por: Shi, HyeJin, et al.
Publicado: (2019)

Synergistic Activity of Niclosamide in Combination With Colistin Against Colistin-Susceptible and Colistin-Resistant Acinetobacter baumannii and Klebsiella pneumoniae
por: Ayerbe-Algaba, Rafael, et al.
Publicado: (2018)

Colistin versus Colistin Combined with Ampicillin-Sulbactam for Multiresistant Acinetobacter baumannii Ventilator-associated Pneumonia Treatment: An Open-label Prospective Study
por: Makris, Demosthenes, et al.
Publicado: (2018)

Risk factors and clinical responses of pneumonia patients with colistin-resistant Acinetobacter baumannii-calcoaceticus
por: Aydemir, Hande, et al.
Publicado: (2019)

Transition of colistin dependence into colistin resistance in Acinetobacter baumannii
por: Lee, Ji-Young, et al.
Publicado: (2017)

In vitro activity of colistin in antimicrobial combination against carbapenem-resistant Acinetobacter baumannii isolated from patients with ventilator-associated pneumonia in Vietnam
por: Le Minh, Vien, et al.
Publicado: (2015)

In vitro Activity of Colistin in Combination with Tigecycline against Carbapenem-Resistant Acinetobacter baumannii Strains Isolated from Patients with Ventilator-Associated Pneumonia
por: Cikman, Aytekin, et al.
Publicado: (2015)

The effectiveness of colistin/levofloxacin compared to colistin/meropenem in the treatment of ventilator-associated pneumonia (VAP) caused by carbapenem-resistant Acinetobacter baumannii: a randomized controlled clinical trial
por: Momenzadeh, Mahnaz, et al.
Publicado: (2022)

Colistin Therapy in a 23-Week Gestational-Age Neonate with Multidrug-Resistant Acinetobacter baumannii Pneumonia
por: Lulic-Botica, Mirjana, et al.
Publicado: (2011)

In Vitro Synergistic Activity of Antimicrobial Combinations against Carbapenem- and Colistin-Resistant Acinetobacter baumannii and Klebsiella pneumoniae
por: Mantzana, Paraskevi, et al.
Publicado: (2023)

Colistin Dependency among Colistin-Heteroresistant Acinetobacter baumannii Isolates
por: Kon, Hadas, et al.
Publicado: (2021)

Retrospective Assessment of Ventilator-Associated Pneumonias due to Acinetobacter baumannii in an Oncology Hospital
por: Canturan, Sevil Yesim, et al.
Publicado: (2021)

Acinetobacter baumannii nosocomial pneumonia: is the outcome more favorable in non-ventilated than ventilated patients?
por: Yang, Ya-Sung, et al.
Publicado: (2013)

Comparison of Intravenous Ampicillin–sulbactam Plus Nebulized Colistin with Intravenous Colistin Plus Nebulized Colistin in Treatment of Ventilator Associated Pneumonia Caused by Multi Drug Resistant Acinetobacter Baumannii: Randomized Open Label Trial
por: Pourheidar, Elham, et al.
Publicado: (2019)

In vivo bactericidal effect of colistin–linezolid combination in a murine model of MDR and XDR Acinetobacter baumannii pneumonia
por: Ma, Xiao-Lin, et al.
Publicado: (2020)

In vivo efficacy of combination of colistin with fosfomycin or minocycline in a mouse model of multidrug-resistant Acinetobacter baumannii pneumonia
por: Ku, Nam Su, et al.
Publicado: (2019)

Clinical Outcomes and Safety of Meropenem–Colistin versus Meropenem–Tigecycline in Patients with Carbapenem-Resistant Acinetobacter baumannii Pneumonia
por: Park, Jae-Min, et al.
Publicado: (2021)

Frequency of Multi-Drug Resistance and Molecular Characteristics of Resistance to Colistin in Acinetobacter baumannii Collected from Patients in Intensive Care Units with Ventilator-Associated Pneumonia
por: Babaei, Samaneh, et al.
Publicado: (2021)

Efficacy of cefiderocol- vs colistin-containing regimen for treatment of bacteraemic ventilator-associated pneumonia caused by carbapenem-resistant Acinetobacter baumannii in patients with COVID-19
por: Russo, A., et al.
Publicado: (2023)

Effect of Inhaled Colistin on the Treatment of Ventilator-Associated Pneumonia due to Multi-drug Resistant Acinetobacter
por: Moradi Moghaddam, Omid, et al.
Publicado: (2019)

Prognostic factors associated with mortality of drug-resistant Acinetobacter baumannii ventilator-associated pneumonia
por: Inchai, Juthamas, et al.
Publicado: (2015)

2557. Development of Rabbit Models of Ventilator-Associated Carbapenem-Resistant Acinetobacter baumannii Pneumonia
por: Petraitis, Vidmantas, et al.
Publicado: (2023)

Meta-analysis of colistin for the treatment of Acinetobacter baumannii infection
por: Chen, Zhijin, et al.
Publicado: (2015)

Curcumin alleviates persistence of Acinetobacter baumannii against colistin
por: Kaur, Amanjot, et al.
Publicado: (2018)

Two types of colistin heteroresistance in Acinetobacter baumannii isolates
por: Hong, Yoon-Kyoung, et al.
Publicado: (2020)

New Mutations Involved in Colistin Resistance in Acinetobacter baumannii
por: Sun, Bingbing, et al.
Publicado: (2020)

Colistin Treatment Affects Lipid Composition of Acinetobacter baumannii
por: Tao, Ye, et al.
Publicado: (2021)

Colistin Resistance in Acinetobacter baumannii: Molecular Mechanisms and Epidemiology
por: Novović, Katarina, et al.
Publicado: (2023)

PYED-1 Overcomes Colistin Resistance in Acinetobacter baumannii
por: Stabile, Maria, et al.
Publicado: (2023)

776 Acinetobacter baumannii ventilator acquired pneumonia in a high density unit of North India
por: Sharma, Navneet, et al.
Publicado: (2014)

Epidemiology and mortality outcome of carbapenem- and colistin-resistant Klebsiella pneumoniae, Escherichia coli, Acinetobacter baumannii, and Pseudomonas aeruginosa bloodstream infections
por: Balkhair, A., et al.
Publicado: (2023)

Role of immunodeficiency in Acinetobacter baumannii associated pneumonia in mice
por: Liu, Ai-Ran, et al.
Publicado: (2020)

Pseudomembranous Aspergillus tracheobronchitis with secondary Acinetobacter baumannii pneumonia
por: Mahismita, Patro, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_vb4ur8lk6ak8odjuruucnspcuj